| 3.68 |  +0.01 / +0.27% |
Data as of 4:00pm ET | Day’s Change |
| 3.68 |  0.00 / 0.00% |
Volume: 20.4K |
| Previous close | 3.67 |
| Today’s open | 3.65 |
| Day’s range | 3.53 - 3.72 |
| Volume | 249,360 |
| Average volume (3 months) | 657,991 |
| Market cap | $260.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +62.50% |
| Earnings growth (this year) | +102.39% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +10.52% |
| P/E ratio | NM |
| Price/Sales | 0.75 |
| Price/Book | 0.94 |
| Today’s change | Today’s % change | |
|---|---|---|
| AXDXAccelerate Diagnosti... | +0.35 | +4.24% |
| HBIOHarvard Bioscience I... | +0.13 | +2.58% |
| VRMLVermillion Inc | -0.06 | -1.91% |
| NEWPNewport Corp | +0.01 | +0.07% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | -$0.00 |
| Annual revenue (last year) | $295.6M |
| Annual profit (last year) | -$10.7M |
| Net profit margin | -3.62% |
Sector Health Technology |
Industry Biotechnology |
Chairman Stephen P. A. Fodor, PhD |
President, Chief Executive Officer & Director Franklin R. Witney, PhD |
Corporate headquarters Santa Clara, California |
.
